Prevalence of wasting among under 6-month-old infants in developing countries and implications of new case

Marko Kerac1, Hannah Blencowe, Carlos Grijalva-Eternod

  • 1Centre for International Health and Development, UCL Institute of Child Health, London, UK. marko.kerac@gmail.com

Insights

New World Health Organization (WHO) standards significantly increase the estimated prevalence of wasting in infants under 6 months. This highlights a greater disease burden, especially for severe wasting, requiring policy consideration.

Area of Science:

  • Global child health
  • Pediatric nutrition
  • Public health surveillance

Background:

  • Infant wasting is a critical global health issue.
  • Accurate prevalence data is essential for effective interventions.
  • Growth references impact disease burden estimation.

Purpose of the Study:

  • To determine wasting prevalence in infants under 6 months.
  • To assess the impact of new World Health Organization (WHO) growth standards on prevalence estimates.
  • To compare wasting prevalence using WHO standards versus National Center for Health Statistics (NCHS) references.

Main Methods:

  • Secondary analysis of Demographic and Health Survey data.
  • Inclusion of 15,534 infants under 6 months and 147,694 children aged 6 to 59 months from 21 developing countries.
  • Wasting defined by weight-for-height z-scores (<-2), with moderate wasting (-3 to <-2) and severe wasting (<-3).

Main Results:

  • WHO standards more than double infant wasting prevalence compared to NCHS references (median 15% vs 3.7%).
  • Estimated number of wasted infants under 6 months increases from ~3 million to ~8.5 million globally.
  • The increase in prevalence, particularly for severe wasting, is more pronounced in infants under 6 months than in older children.

Conclusions:

  • Wasting is prevalent among infants under 6 months in developing countries, regardless of the reference standard used.
  • Adoption of WHO standards significantly increases the estimated disease burden of infant wasting.
  • Policymakers and health programs must consider the implications of changing case definitions on resource allocation and risk assessment.
Abstract

Related Concept Videos

Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
International Nursing Organizations II01:28

International Nursing Organizations II

The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
Anorexia Nervosa01:28

Anorexia Nervosa

Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is: